Salient Advisory studies innovations in healthtech across the African continent. This newsletter summarizes the most interesting news we read each month. Submissions are welcome. Feel free to share.
New Report: AI Applications in African Health Supply Chains
Health supply chains across Africa face several challenges, including frequent stockouts, slow manual processes, and fragmented data, which hinder supply chain planning and operations. However, AI-powered solutions that address these problems are beginning to emerge.
Salient Advisory’s new report, AI Applications in African Health Supply Chains: Landscape of Solutions and Emerging Impacts, identifies key supply chain problems where AI appears most amenable to delivering impact today, maps the deployed AI solutions addressing them, and profiles real-world examples of AI solutions from across the continent.
Read the full report here.
WHO and Japan back new tools to strengthen African digital health and disease control
The World Health Organization (WHO) joined the Open Health Stack Software Foundation, a new global open-source foundation dedicated to advancing standards-based digital health infrastructure, to help countries build interoperable, nationally-owned digital health systems. The Foundation will provide free, open-source tools and reference software built on international standards, reducing countries’ reliance on isolated, donor-funded platforms.
The National Malaria Elimination Program in Ghana, with funding from the Government of Japan, launched a pilot study assessing whether drones and AI can strengthen larval source management in hard-to-reach wetlands. Implemented with UNDP’s Access and Delivery Partnership, SORA Technology, and the Special Programme for Research and Training in Tropical Diseases, the approach combines aerial mapping, AI-assisted identification of mosquito breeding sites, and drone-based larvicide spraying, treating sites in under an hour compared to several days using conventional methods.
African health manufacturers attract investment to scale local production capacity
Biovac, a South African biopharmaceutical company, secured a $15 million loan from the African Development Bank to support construction of a new multi-vaccine manufacturing facility in Cape Town. When complete, the facility will produce vaccines for cholera, polio, pneumonia, and meningitis, making Biovac Africa’s first end-to-end producer of oral cholera vaccine and increasing its annual manufacturing capacity to 500 million doses.
Reme-D, an Egyptian healthtech company, raised $1.45 million in a Pre-Series A round led by Anara Impact Capital, with participation from the Global Innovation Fund and Africa Health Ventures. Founded in 2023, Reme-D manufactures molecular diagnostic tests for TB, HIV, hepatitis, and HPV that are engineered to remain stable at higher temperatures, eliminating cold-chain dependency for last-mile deployment. The new capital will fund a tenfold increase in manufacturing capacity and expansion into genetic disease and cancer diagnostics.
A standout maternal health startup continues strong 2026 run with a global recognition award
HelpMum Africa, a Nigerian healthtech startup building AI-powered tools for maternal and child health, won the Grand Prize for AI for Social Impact at Prix Ars Electronica 2026. HelpMum was honored for its suite of WhatsApp-based tools, MamaBot AI, VaxAI, and StratifyAI, which are designed to close gaps in maternal and child health outcomes in rural and low-connectivity communities across Nigeria. The award follows HelpMum’s selection as one of 18 grantees in the ICONIQ Impact $100 million Child Survival Portfolio earlier this year.
Recommended Read
New analysis from TechBuild Africa provides a comprehensive overview of the state of healthtech in East Africa, covering funding trends, emerging AI applications, and barriers to scale. It also spotlights contrasting government approaches to digital health: Kenya’s market-driven model versus Rwanda’s state-led digitization strategy.
Spread the word! Share this with African healthtech innovators, donors, investors, and enthusiasts within your network – and encourage them to sign up

